The Asia Pacific Prefilled Syringes Market would witness market growth of 11.0% CAGR during the forecast period (2022-2028).
Prefilled syringes for medical treatment are now available outside of hospitals due to its simple usage among patients to self-administer several kinds of injectable medications. Prefilled syringes have a wide range of compelling advantages, like simplicity, adaptability for home usage, a decrease in product waste, and higher dose precision, thus it is not unexpected that they are so widely accepted. Easy prefilled forms facilitate administration. The patient does not need to be concerned about the transferring of a medication from a vial to a syringe and is therefore not concerned about losing a small amount of the prescribed dose behind.
Prefilled medications increase patient safety by lowering the risk of accidental needle sticking and product exposure which can happen when taking medication from vials. With the pre-measured dosage, prefilled syringes can decrease dosing errors and improve patient compliance. Prefilled syringes practically eliminate the requirement for manufacturers to overfill, in contrast to vials, which are typically overfilled by as much as 20–30% to compensate for potential wastage. This is especially crucial where manufacturing and product prices are significant and bulk production capabilities is limited.
The region's market is anticipated to increase as a result of favorable demographic variables including the huge population and rising prevalence of different chronic diseases. The market for developed prefilled syringes is made up of nations like China. In addition, nations like Japan and India provide significant growth potential by luring key firms to their markets through rising foreign direct investment (FDI) and product demand.
The China market dominated the Asia Pacific Prefilled Syringes Market by Country in 2021; thereby, achieving a market value of $996.1 million by 2028. The Japan market is anticipated to grow at a CAGR of 10.3% during (2022 - 2028). Additionally, The India market would exhibit a CAGR of 11.7% during (2022 - 2028).
Based on Application, the market is segmented into Diabetes, Anaphylaxis, Rheumatoid Arthritis, and Others. Based on Therapeutics, the market is segmented into Large Molecules and Small Molecules. Based on Material, the market is segmented into Glass-based and Plastic-based. Based on Design, the market is segmented into Single-chamber, Dual-chamber, and Customized. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Prefilled Syringes Market is Projected to reach USD 11.9 Billion by 2028, at a CAGR of 10.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Bayer AG, Baxter International, Inc., Becton, Dickinson and Company, Gerresheimer AG, Medtronic PLC, Nipro Corporation, Terumo Corporation, Vetter Pharma, West Pharmaceutical Services, Inc.
By Application
By Therapeutics
By Material
By Design
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
